Anti-SARS-CoV-2 (RBD) IgG quAnti | KZ-540-12

Anti-SARS-CoV-2 (RBD) IgG quAnti | KZ-540-12 | Vidia spol s.r.o.

Test Principle: The principle of mono-tests, MONO-VIDITEST, is based on an indirect ELISA method for determining the content of specific Antibodies in samples. The kits are intended for quAntitative / semi-quAntitative evaluation of IgA, IgM and IgG class of Antibodies in serum, plasma, cerebrospinal fluid and synovial fluid samples. All MONO-VIDITEST kits have unified incubation times and washing steps. This benefit supports the testing of different MONO-VIDITEST diagnostic kits in one run. MONO-VIDITEST kits monitor the patient's examination by individual sample, which leads to a faster result, savings in material and personnel costs of the medical device.